Context Therapeutics Inc. — Investor Relations & Filings
Context Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to advancing treatments for solid tumors. The company develops next-generation T cell engaging (TCE) bispecific antibody therapies designed to harness the patient's immune system for targeted cancer eradication. Its pipeline features innovative immunotherapeutic solutions for difficult-to-treat solid tumors. Key portfolio highlights include CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody; CT-95, an avidity-enhanced mesothelin (MSLN) x CD3 bispecific antibody; and CT-202, a dual pH-dependent Nectin-4 x CD3 bispecific antibody.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-18 | English | |
| ARS - Context Therapeutics Inc. (0001842952) (Filer) | 2026-04-28 | English | |
| 8-K - Context Therapeutics Inc. (0001842952) (Filer) | 2026-04-02 | English | |
| S-8 - Context Therapeutics Inc. (0001842952) (Filer) | 2026-03-23 | English | |
| 8-K - CONTEXT THERAPEUTICS INC. (0001842952) (Filer) | 2026-02-27 | English | |
| 4 - CONTEXT THERAPEUTICS INC. (0001842952) (Filer) | 2026-02-23 | English |
Browse filings by year
6 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CATALYST PHARMACEUTICALS, INC.
Biopharmaceutical company commercializing drugs for rare ne…
|
CPRX | US | Manufacturing |
|
cbdMD, Inc.
Producer and distributor of health and wellness CBD product…
|
YCBD | US | Manufacturing |
|
CCSB
Specialized manufacturer of APIs for oncology, antifungal, …
|
1762 | TW | Manufacturing |
|
CDT Equity Inc.
A clinical-stage biopharmaceutical firm advancing assets fo…
|
CDT | US | Manufacturing |
|
Ceapro Inc.
Develops and commercializes natural active ingredients deri…
|
CZO | CA | Manufacturing |
|
CELADON PHARMACEUTICALS PLC
Researches, cultivates, and manufactures cannabinoid-based …
|
CEL | GB | Manufacturing |
|
Celemics, Inc.
Develops NGS target enrichment solutions for research and c…
|
331920 | KR | Manufacturing |
|
Cellbion Co., Ltd
Develops radiopharmaceuticals and radioligand therapies for…
|
308430 | KR | Manufacturing |
|
CELL BIOTECH CO ., LTD
Develops and manufactures probiotic solutions using patente…
|
049960 | KR | Manufacturing |
|
Celldex Therapeutics, Inc.
Develops antibody-based immunotherapies for severe inflamma…
|
CLDX | US | Manufacturing |
Context Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34269/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34269 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34269 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34269 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34269}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Context Therapeutics Inc. (id: 34269)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.